IPO Listed
Parabilis Medicines IPO
US$670m raised
Lodged 9 Jun 2026 · NASDAQ: PBLS · US$20.00 per share
Advisers
Lead managers
- Legal adviser
- Issuer
- Parabilis Medicines
- Issuer based in
- United States
- Listed
- 12 Jun 2026
- Sector
- Biotech
- Tags
- Biotech, Drug Development, Oncology
In the league tables
Similar deals
- Eikon Therapeutics IPO Feb 2026 · US$381m · Oncology
- Avenzo Therapeutics placement Jun 2026 · US$215m · Biotech
- Sensei Biotherapeutics placement Feb 2026 · US$200m · Biotech
- BlossomHill Therapeutics IPO Aug 2026 · US$150m · Biotech
- Remix Therapeutics placement Jun 2026 · US$100m · Biotech
Sources
- Jun 2026 Guggenheim Securities: Joint Bookrunner to Parabilis Medicines, Inc. on its Initial Public Offering guggenheimsecurities.com
- 10 Jun 2026 Final IPO prospectus (424B4), Parabilis Medicines, Inc. sec.gov
- 12 Jun 2026 Goodwin Guides Parabilis Medicines on Upsized $770.5 Million Initial Public Offering and $75 Million Private Placement to Regeneron Pharmaceuticals goodwinlaw.com



